Christina Wilson, M.D., Ph.D.



christina.wilson@neurology.ufl.edu

Christina Wilson, MD, PhD, an assistant professor of neurology at the University of Florida College of Medicine and is a key member of the only comprehensive stroke program in north central Florida. Dr. Wilson graduated from Furman University in Greenville, South Carolina, with a bachelor’s degree in psychology. She completed her doctorate degree in pharmacology in 2001, and was a postdoctoral research fellow from 2001-2003 at the University of Pennsylvania, Philadelphia. Her research focused on the cell biology of presenilin proteins associated with Alzheimer’s disease, for which she was awarded a Howard Hughes Predoctoral Fellowship. Dr. Wilson completed her medical degree at the University of Pennsylvania and was an intern in internal medicine at the Pennsylvania Hospital, where she was elected Intern of the Year. She then completed her residency in neurology in 2012 at the University of Pennsylvania, and was a neurovascular fellow at the same institution from 2012-2013. Dr. Wilson joined the faculty of the UF department of neurology in 2013. She currently provides stroke care both for hospitalized patients as well as outpatients in the neurovascular clinic. Dr. Wilson also handles didactic training of stroke mechanisms of disease and mentors stroke fellows, medical students and residents. Dr. Wilson’s main interest lies in clinical stroke management. She is the local primary investigator for several national clinical stroke trials and regularly educates the community and EMS about stroke via outreach events. She has also served as the neurology residency program director since 2015. Dr. Wilson is an associate faculty member of the F1000Prime, which identifies and recommends important articles in biology and medical research publications. She is also a member of the American Stroke Association and American Academy of Neurology. She has authored multiple peer-reviewed manuscripts related to neurology, stroke and neuroscience.

 

Education:

8/2003 – 5/2008 MD University of Pennsylvania

9/1995 – 7/2001 PhD University of Pennsylvania (Pharmacology)

9/1991 – 6/1995 BA Furman University

 

Postgraduate Training:

7/2012 – 6/2013 Neurovascular Fellow, University of Pennsylvania

7/2009 – 6/2012 Resident in Neurology, University of Pennsylvania

6/2008 – 6/2009 Intern in Medicine, Pennsylvania Hospital

7/2001 – 7/2003 Post-doctoral fellow, University of Pennsylvania

 

Awards

2009 Pennsylvania Hospital Intern of the Year

1995-2000 Howard Hughes Medical Institute Predoctoral Fellow

 

Publications:

Original papers:

Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, Martinez-Hernandez E, Wilson C, Jacobs D, Lai M, Walker RW, Graus F, Bataller L, Illa I, Markx S, Strauss KA, Peles E, Scherer SS, Dalmau J. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol. 2011;69:303-11.

Pineles SL, Wilson CA, Balcer LJ, Slater R, Galetta SL. Combined optic neuropathy and myelopathy. Surv Ophthalmol. 2010;55:386-92.

Wilson CA, Murphy DD, Giasson BI, Zhang B, Trojanowski JQ, Lee VM. Degradative organelles containing mislocalized a-and b-synuclein proliferate in presenilin-1 null neurons. J Cell Biol. 2004;165(3):335-46.

Crystal AS, Morais VA, Fortna RR, Carlin D, Pierson TC, Wilson CA, Lee VM, Doms RW. Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation. Biochemistry. 2004;43(12):3555-63.

Phiel CJ*, Wilson CA*, Lee VM, Klein PS. GSK-3a regulates production of Alzheimer’s disease amyloid-b peptides. Nature. 2003;423(6938):435-9.

*Co-first authors

Giasson BI, Sampathu DM, Wilson CA, Vogelsberg-Ragaglia V, Mushynski WE, Lee VM. The environmental toxin arsenite induces tau hyperphosphorylation. Biochemistry. 2002;41(51):15376-87.

Wilson CA, Doms RW, Zheng H, Lee VM. Presenilins are not required for Ab42 production in the early secretory pathway. Nat Neurosci. 2002;5(9):849-55.

Muir JK, Raghupathi R, Saatman KE, Wilson CA, Lee VM, Trojanowski JQ, Philips MF, McIntosh TK. Terminally differentiated human neurons survive and integrate following transplantation into the traumatically injured rat brain. J Neurotrauma. 1999;16(5):403-14.

Inglefield JR, Wilson CA, Schwartz-Bloom RD. Effect of transient cerebral ischemia on g-aminobutyric acid receptor a1-subunit-immunoreactive interneurons in the gerbil CA1 hippocampus. Hippocampus. 1997;7(5):511-23.

Editorials, Reviews, Chapters:

Wilson CA, Giasson BI. Potential role of a-synuclein in neurodegenerative diseases of the basal ganglia: Influence of genetic and environmental factors. In Recent Breakthroughs in Basal Ganglia Research. Ed E. Bezard. New York, NY. Nova Science Publishers, Inc., p. 337-350. 2006.

Wilson CA, Doms RW, Lee VM. Distinct presenilin-dependent and presenilin independent g-secretases are responsible for total cellular Ab production. J Neurosci Res. 2003 Nov 1;74(3):361-9.

Giasson BI, Wilson CA, Trojanowski JQ, Lee VM. Tau and a-synuclein in neurodegenerative diseases. In Contemporary Clinical Neuroscience: Molecular Mechanisms of Neurodegenerative Diseases. Ed. M.-F. Chesselet. Totowa, NJ. Humana Press Inc., p. 151-176. 2000.

Wilson CA, Doms RW, Lee VM. Intracellular APP processing and Ab production in Alzheimer disease. J Neuropathol Exp Neurol. 1999;58(8):787-94.